August 14th, 2012 // 12:52 pm @ jmpickett
Regulators on both sides of the Atlantic address the shortages that occur when drugmakers fail to comply with GMP in documents published this week.
Damage Control! How to Handle an FDA Drug or Device Recall – June 12, 2 PM EDT – Moore →
In June, you have the unique opportunity to learn about how to avoid and manage FDA recalls from Dennis Moore,… Read more… →
GotoWebinar: Verification and Validation Planning and Execution – July 24, 1 PM EDT – Lincoln →
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies. One major failing is lack of… Read more… →
GotoWebinar: Bullet-Proof Closed-Loop CAPA, Failure Investigation, and Root Cause Analysis – June 5 – Lincoln →
A company's CAPA System is supposed to be a major tool in resolving product complaint, non-conformance, and focusing OOS failure… Read more… →
Enter your email address
"ExpertBriefings.com always selects excellent speakers – some of the best I have ever heard. Their messages are direct, clear, timely, and relevant."
Anon A. Mouse